Wits professor of Vaccinology, Shabir Madhi is leading a COVID-19 vaccine trial at Wits University in Johannesburg. Currently, the team have begun screening participants for a second coronavirus COVID-19 vaccine trial as of this Monday. About 2900 people are expected to partake in the second COVID-19 vaccine trial in South Africa.
The aim of the trial is to evaluate a particle in the vaccine that protects against the coronavirus in adults aged between 18-and 64. The nanoparticle S-protein, known as NVX-CoV2373, is produced by biotech company, Novavax, in the United States. Listen as Professor Madhi explains on Newsbreak Lotus how this trial will be carried out.
In other news, Western Cape Muslim cleric, Imam Dawood Sampson, has landed in hot water after his derogatory utterances in a video demeaned women.
Source: Newsbreak Lotus
The global lockdown has everyone’s mental health in a spin! Have you checked out our Mental Health resources by Indian Spice click here
The South African Depression And Anxiety Group (SADAG) is Africa’s largest mental health support and advocacy group open 7 days a week from 8am – 8pm. If you are needing a referral to a psychologist, psychiatrist or support group call SADAG on 011 234 4837 or 0800 20 50 26 and speak to a trained counselor who can assist you further. Substance abuse hotline: 0800 12 13 14 is available 24hrs or alternatively email Zane on email@example.com
If you need support or know someone who does, please reach out to your nearest mental health specialist. India Helplines: Aasra: 022 2754 6669; Sneha India Foundation: +914424640050 and Sanjivini: 011-24311918
Stay at home if you feel unwell. If you have a fever, cough and difficulty breathing, seek medical attention and call in advance. Follow the directions of your local health authority during the coronavirus crisis.
Connect with the Coronavirus Whatsapp services below
- Coronavirus India Whatsapp tap here
- Coronavirus South Africa Whatsapp tap here
- SA Hotline Number: 0800 029 999
For more related coronavirus (COVID-19) latest news and stories click here